Submitted by Anonymous (not verified) on 19 September 2023 - 11:42
Human medicines European public assessment report (EPAR): Steglujan, ertugliflozin,sitagliptin, Diabetes Mellitus, Type 2, Date of authorisation: 23/03/2018, Revision: 11, Status: Authorised
Source: